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Introduction
Dynamin was first identified as a microtubule-binding protein 
(Shpetner and Vallee, 1989, 1992; Scaife and Margolis, 1990; 
Maeda et al., 1992). However, the importance of its association 
with microtubules was questioned after the establishment of a 
function for dynamin in endocytosis. Dynamin is a homologue 
of the Drosophila melanogaster shibire gene (Chen et al., 1991),   
mutations in dynamin block endocytosis, and dynamin’s GTPase 
activity is crucial for the fission of endocytic pits. Polymerized 
dynamin rings have been proposed to function as a pinchase 
(Urrutia et al., 1997) or poppase (Stowell et al., 1999) or by a 
molecular switch mechanism requiring subsequent activation of 
a downstream substrate (Sever et al., 2000).
Three dynamin isoforms have been identified in mam-
mals. Dynamin 1 (dyn1) and dyn3 are tissue specific (neurons 
and brain for dyn1; testis, lung, and heart for dyn3), whereas 
dyn2 is ubiquitously expressed. Dynamin has five characteristic 
domains: a GTPase domain in its N terminus, a middle domain 
that binds to -tubulin; a pleckstrin homology (PH) domain that 
binds to phosphinositide-4,5-diphosphate and leads to mem-
brane localization, a GTPase effector domain, and a pro-rich 
domain in the C terminus. The pro-rich domain binds to various 
SH3 domain–containing proteins and microtubules (Herskovits 
et al., 1993b).
Recently, dyn2 mutations were found to be associated 
with  Charcot-Marie-Tooth  (CMT)  neuropathies  (Zuchner   
et al., 2005), but the molecular and cellular mechanisms of 
dyn2’s involvement in disease pathogenesis are still unclear. 
The CMT hereditary motor and sensory neuropathies fall into 
two main groups. CMT type 1 includes demyelinating forms 
of the disease in which nerve conduction velocities (NCVs) 
are reduced; CMT type 2 includes the axonal forms in which 
NCVs are normal, but conduction amplitudes are decreased 
(Suter and Scherer, 2003). There are also dominant intermedi-
ate (DI) subtypes of CMT, denoted DI-CMTA, DI-CMTB, and 
DI-CMTC, that are characterized by both axonal and demyelinat-
ing NCVs (Kennerson et al., 2001; Verhoeven et al., 2001;   
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and that increased microtubule stability is one feature of CMT 
that is linked to mutations in dynamin.
Results and discussion
We assessed whether expression of the CMT-associated 5513 
and K558E dyn2 mutants inhibits endocytosis by transfecting 
COS-7 cells with dyn2 cDNAs and examining uptake of Alexa 
Fluor  488–transferrin. As  a  positive  control,  the  cells  were 
transfected with K44A, a GTPase-negative dyn2 mutant which 
is known to inhibit endocytosis (Herskovits et al., 1993a;   
Jordanova et al., 2003). DI-CMTB patients have mutations 
within the dyn2 PH domain, including the deletion mutant 
5513 and the point mutant K558E (Zuchner et al., 2005). 
This suggests that the impairment in CMT may be caused   
by an inability to form active dynamin polymers, which are 
needed  to  bind  and  then  deform  membranes  to  carry  out   
peripheral cell functions (McNiven, 2005). In this study, we 
investigated the effect of the 5513 mutation on dyn2 function 
and found that it induces the accumulation of stable micro-
tubules, as does the reduction of endogenous dyn2, indicating 
that dyn2 regulates the dynamic instability of microtubules 
Figure  1.  Expression  of  the  5513  dyn2 
mutant  does  not  inhibit  transferrin  endo-
cytosis.  COS-7  cells  were  transfected  with 
the  indicated  constructs  and  incubated  with 
Alexa  Fluor  488–transferrin  for  30  min.   
(A) Schematic representation of dyn2 indicat-
ing functional domains and mutation sites used 
in this experiment. GED, GTPase effector do-
main. (B) The expression levels of exogenous 
proteins  were  confirmed  by  immunoblotting 
using  anti-V5.  (C)  Confocal  micrographs 
showing  the  subcellular  distribution  of  inter-
nalized transferrin (Tfn; green) in transfected 
cells (red). (D) Quantification of the effect of 
the indicated constructs on transferrin internal-
ization. The number of cells containing Alexa 
Fluor 488–transferrin is expressed relative to 
the total number of transfected cells. (E) Effect 
of the 5513 dyn2 mutant on the perinuclear 
localization  of  internalized  transferrin.  The 
number of cells with perinuclear transferrin is 
expressed relative to the total number of trans-
fected cells. Error bars indicate SD from two 
independent experiments; *, P < 0.005. WT, 
wild type. Bar, 20 µm.941 DYNAMIN REGULATES MICROTUBULE INSTABILITY • Tanabe and Takei
(Zuchner et al., 2005). Moreover, dynamin was originally identi-
fied as a microtubule-associated protein (Shpetner and Vallee, 
1989). Both dyn1 and dyn2 polymerize around microtubules, 
and these interactions lead to the stimulation of dynamin GTPase 
activity (Maeda et al., 1992; Warnock et al., 1997).
To test whether dyn2 localizes along microtubules, we 
transfected COS-7 cells with wild-type or 5513 dyn2 cDNA 
constructs tagged with the V5 epitope. Microtubules were visu-
alized by immunostaining for -tubulin. Immunostaining with 
antibodies to V5 indicated that wild-type dyn2 was present in a 
punctate pattern on the plasma membrane as well as in sub-
stantial amounts in the cytosol, where the puncta seemed to co-
localize with the microtubules (Fig. 2, A–C). 5513 dyn2 also 
colocalized  with  and  prominently  decorated  microtubules   
van der Bliek et al., 1993). Although expression of either the 
K558E or K44A mutant completely blocked endocytosis (Fig. 1, 
A and B; Zuchner et al., 2005), expression of 5513 did not 
(Fig. 1, A and B). However, the transferrin-containing compart-
ments in the 5513-transfected cells no longer accumulated at 
the perinuclear region (Fig. 1 C) but were instead transported to 
early and recycling endosomes (Fig. S1). Internalized transferrin-
containing endosomes are transported along microtubules by 
dynein–dynactin complexes to perinuclear recycling endosomes 
(Burkhardt et al., 1997). Therefore, it is likely that processes   
involved in capturing endosomes or traveling along micro-
tubules are impaired in 5513-expressing cells. Supporting this 
microtubule-related role for dyn2, it has previously been shown 
that 5513 expression induces microtubule reorganization 
Figure 2.  Dyn2 remains associated with microtubules after the extraction of soluble proteins. (A–L) COS-7 cells were transfected with the indicated con-
structs and incubated with antibodies specific for V5 (A, D, G, and J) or -tubulin (B, E, H, and K), and the V5 and -tubulin images were merged 
(C, F, I, and L). To extract the cytosolic proteins, the cells were incubated with Triton X-100 (TX100) before fixation and processed for immunofluorescence 
(D–F and J–L). The boxed areas are enlarged in the insets. WT, wild type. Bar, 10 µm.JCB • VOLUME 185 • NUMBER 6 • 2009   942
Taxol inhibits microtubule depolymerization and thus pre-
vents normal dynamic instability (Green and Goldman, 1983). 
Therefore, we tested whether the dyn2 mutants could have the 
same effect. Acetylation distinguishes stable microtubules from 
dynamic microtubules (Piperno et al., 1987; Westermann and 
Weber, 2003), although tubulin acetylation itself does not pro-
mote microtubule stability (Palazzo et al., 2003). Accordingly, 
we assessed the effect of 5513 expression in COS-7 cells on 
microtubule acetylation. Expression of wild-type, K44A, or 
(Fig. 2, G–I), as previously reported (Zuchner et al., 2005).   
To more clearly demonstrate the association of dyn2 with micro-
tubules, we performed immunolocalization after cytosolic pro-
teins were extracted from cells with Triton X-100. Both wild-type 
dyn2 (Fig. 2, D–F) and 5513 (Fig. 2, J–L) clearly colocalized 
with the microtubules in these conditions (Zuchner et al., 2005). 
These results indicate that a subpopulation of dyn2 molecules 
localizes to microtubules in vivo and that the 5513 mutation 
may alter the microtubule-binding properties of dyn2.
Figure 3.  Expression of the 5513 dyn2 mutant causes the accumulation of acetylated tubulin. (A) COS-7 cells were transfected with the indicated con-
structs, fixed 48 h later, and visualized with antibodies specific for V5 (red) and acetylated-tubulin (Acet-tubulin; green). (B and C) The expression level of 
V5-tagged proteins (B) and the level of acetylated tubulin against the V5 signals (C) were measured and averaged. Approximately 50 cells were used, and 
the data are represented in arbitrary units (a.u.). Error bars indicate SD; *, P < 0.005. WT, wild type. Bar, 20 µm.943 DYNAMIN REGULATES MICROTUBULE INSTABILITY • Tanabe and Takei
changed by dyn2 depletion (Table I). This indicates that dyn2   
depletion does not affect the microtubule polymerization or de-
polymerization mechanisms but rather increases the duration of 
microtubule pause. This implies that wild-type dyn2 increases 
the frequency of microtubule growth and/or shrinkage.
Next, we investigated how the effect of dyn2 on micro-
tubules contributes to cellular activities. Because impaired   
dynamic instability of microtubules is suggested to inhibit traf-
ficking along microtubules (Mimori-Kiyosue and Tsukita, 2003; 
Vaughan, 2005) and Golgi apparatus formation is dependent on 
microtubule-mediated  transport  (Thyberg  and  Moskalewski, 
1999), we examined Golgi formation in dyn2 siRNA cells and 
5513-expressing cells. External tracers could not be used to 
directly  monitor  microtubule-dependent  transport  in  these   
experiments because they cannot be internalized by the dyn2 
siRNA cells (Thyberg and Moskalewski, 1999). As expected, 
the Golgi complex was dispersed in 90% of dyn2 siRNA cells 
(Fig. 5 A, left). The fragments of the Golgi complex maintained 
characteristic cisternal stack morphologies, as judged with double-
immunofluorescence  staining  using  cis/medial  (GRASP65)- 
and trans (p230)-Golgi markers (Fig. 5 A, right) and with 
electron microscopy (Fig. 5 B).
To rule out the possibility that the Golgi fragmentation in 
dyn2 siRNA cells is an indirect effect of endocytotic blockade, 
we analyzed Golgi formation in the 5513-expressing cells, in 
which dyn-dependent endocytosis is not blocked (Fig. 1). As 
controls, we also examined Golgi formation in K44A- and 
K558E-expressing cells, in which endocytosis is blocked (Fig. 1). 
Unlike expression of either K44A or K558E, 5513 expression 
induced Golgi fragmentation (Fig. S3). Thus, the Golgi frag-
mentation in dyn2 siRNA cells is not caused by the inhibition of 
dynamin-dependent endocytosis but is more likely the result of 
impaired organelle transport, which is dependent on normal 
microtubule dynamic instability. The regulation of microtubule 
stability by dyn2 seems to be independent of its GTPase activity 
because the K44A mutant had no effect on microtubule-dependent 
organelle transport (Fig. S3 B). Similarly, the role of dyn2 in 
centrosome cohesion does not require its GTP domain (Thompson   
et al., 2004). Therefore, it is possible that dyn2 can function as 
a structural protein independently of its GTPase activity.
How is microtubule-dependent transport impaired by dyn2 
depletion or expression of the 5513 mutation? One possi-
bility is that minus end–oriented motor proteins are inhibited   
in these cells. Supporting this, inhibition of these motor proteins 
has been observed when dynamitin, a subunit of the dynein– 
dynactin complex, is overexpressed (Burkhardt et al., 1997). 
Alternatively, dyn2 depletion and 5513 expression may impair 
the capture of pre-Golgi intermediates onto microtubules. To 
examine these two possibilities, we analyzed the movement of 
the fragmented Golgi in dyn2-depleted HeLa cells. For this pur-
pose, HeLa cells expressing N-acetylglucosaminyltransferase I 
(NAGT)–GFP, a Golgi marker, were transfected with different 
dyn2 siRNA constructs, and Golgi fragmentation was induced by 
nocodazole treatment. The nocodazole was then washed out to 
allow microtubule polymerization, and the movement of the frag-
mented Golgi during the recovery phase was observed by live cell 
imaging. In control cells, the fragmented Golgi eventually moved 
K558E dyn2 did not alter the degree of microtubule acetylation 
(Fig. 3 A and not depicted). In contrast, 5513 expression re-
sulted in a massive accumulation of acetylated tubulin (Fig. 3 A). 
Quantitative image analysis revealed a significant increase of 
acetylated tubulin in 5513-expressing cells (the fluorescence 
intensity ratios of acetylated tubulin to dynamin-V5 were 3.9 ± 
1.8 and 2.4 ± 1.1 in 5513 and wild-type cells, respectively;   
n = 30, P < 0.05), with no significant difference in total tubulin 
expression between 5513 and the wild type (Fig. 3, B and C). 
Thus, the differential microtubule-binding patterns observed in 
5513-expressing cells are likely caused by the abnormal accu-
mulation of acetylated microtubules.
We then asked whether the 5513-induced accumulation 
of acetylated microtubules is caused by a loss of function or a 
gain of function of dyn2. To this end, we examined the effect of 
siRNA-mediated depletion of endogenous dyn2 on microtubule 
stability in HeLa cells. Two different dyn2-specific siRNAs suc-
cessfully knocked down endogenous dyn2 in HeLa cells (Fig. S2), 
and transferrin internalization was inhibited (not depicted), as 
reported previously (Huang et al., 2004). Immunofluorescence 
of the dyn2 siRNA–treated (dyn2 siRNA) cells did not show 
any apparent reorganization of microtubules (Fig. 4 A). How-
ever, Western blot and immunofluorescence analyses revealed 
that these cells had an approximately twofold increase in acety-
lated tubulin, although the total tubulin protein levels did not 
change (Fig. 4, A and B). In addition, localization of EB1 to the 
plus end of dynamic/growing microtubules in control siRNA–
treated cells (Mimori-Kiyosue and Tsukita, 2003) was signifi-
cantly reduced in dyn2 siRNA cells (Fig. 4 A and Fig. S2, D and E), 
whereas total EB1 protein levels were unchanged (Fig. 4 B). 
In contrast, the minus ends of microtubules were not affected by 
the siRNA treatment, as judged by staining pericentrin (Fig. 4 A) 
or -tubulin (not depicted). These results indicate that depletion 
of endogenous dyn2, like the 5513 mutant, induces the accu-
mulation of acetylated microtubules and reduces the proportion 
of  dynamic/growing  microtubules. Thus,  the  5513-induced 
accumulation of stable microtubules is caused by a loss of micro-
tubule-related dyn2 function.
To further confirm the effect of dyn2 depletion on micro-
tubule stability, we performed the following two experiments. 
First, we treated siRNA-transfected HeLa cells with nocodazole, 
which is an inhibitor of microtubule polymerization. As the half 
life of stable microtubules (1 h) is much longer than that of 
dynamic microtubules (5–10 min; Schulze et al., 1987), no-
codazole is expected to be more effective on dynamic micro-
tubules. Nocodazole treatment for up to 1 h resulted in the 
disappearance of microtubules in control cells, whereas micro-
tubules persisted in dyn2 siRNA cells (Fig. 4, C and D). Next, 
we analyzed the effect of dyn2 siRNA on HeLa cells that stably 
express  GFP-tubulin.  In  control  cells,  microtubules  showed   
repeated growth and shrinkage, a behavior known as dynamic 
instability (Mitchison and Kirschner, 1984), whereas growth and 
shrinkage were less frequently observed in dyn2 siRNA cells 
(Fig. 4 E and Video 1). Thus, dyn2 depletion indeed induces 
stable microtubule accumulation. Analysis of various microtubule 
dynamic instability parameters in dyn2 siRNA cells revealed that 
neither the growth rate nor the shortening rate was significantly JCB • VOLUME 185 • NUMBER 6 • 2009   944
Figure 4.  Depletion of endogenous dyn2 by RNAi results in stable microtubule accumulation. HeLa cells were transfected with control or dyn2-specific 
siRNA. (A) Immunofluorescence of RNAi-treated cells. The cells were fixed and visualized with antibodies specific for -tubulin, acetylated tubulin (Acet-
tubulin), EB1, and pericentrin. (B) Western blot analysis of the cells transfected with control or dyn2 siRNA. The blots were visualized with the indicated 
antibodies. (C and D) Dyn2 siRNA–treated cells are resistant to nocodazole treatment. The cells were incubated with nocodazole for 30 or 60 min and 
then fixed and visualized with anti–-tubulin. The images in C show the cells after 30 min of nocodazole treatment. In D, the cells with intact microtubules 
are expressed relative to the total number of cells. The results represent the mean ± SD from two independent experiments. (E) The microtubules are less 
dynamic in dyn2 siRNA–treated cells. HeLa cells stably expressing GFP-tubulin were transfected with control or dyn2 siRNA, and images were collected 
every 2 s. Representative microtubules are indicated by arrows. Bars: (A and C) 10 µm; (E) 2 µm.945 DYNAMIN REGULATES MICROTUBULE INSTABILITY • Tanabe and Takei
transport (Fig. 3). This is consistent with observations that sug-
gest neuropathies, including CMT, are caused by defects in 
membrane transport steps such as endocytosis, axonal transport, 
or protein degradation (Suter and Scherer, 2003). Notably, all of 
the dyn2 mutations that are associated with CMT, including 
5513 and K558E, are located in the PH domain (Zuchner et al., 
2005). The predicted structures of these mutant PH domains in-
dicate that 5513 but not K558E impairs the proper formation 
of the 3/4 loops, which is required for dyn2 dimerization. 
This implies that the decoration of microtubules induced by 
5513, not by dyn2 depletion, may be caused by the abnormal 
polymerization activity of 5513 resulting from the loss of dyn2 
dimerization. In other words, wild-type dyn2 may contribute to 
the correct bundling of microtubules through its polymerization 
activity. Interestingly, dynamin was identified previously as a 
microtubule-binding protein (Shpetner and Vallee, 1989) that 
cross-links microtubules to form bundles in vitro (Scaife and 
Margolis, 1990; Maeda et al., 1992; Shpetner and Vallee, 1992). 
Dynamin also increases its GTPase activity when it polymerizes 
around microtubules (Warnock et al., 1997). However, the physio-
logical significance of these observations was unclear. This 
study is the first indication that dyn2 plays a role in the regula-
tion of dynamic instability of microtubules in vivo and that this 
function of dyn2 is essential for microtubule-dependent mem-
brane transport. However, the fact that dyn2 localizes at the   
microtubule bundle in cytokinesis (Thompson et al., 2002) and 
at the centrosome (Thompson et al., 2004) implies it has even 
more diverse microtubule-related functions, the elucidation of 
which will also require further study.
Materials and methods
Reagents and antibodies
All chemicals and reagents were of biochemical grade. Nocodazole was 
purchased  from  Sigma-Aldrich.  The  following  primary  antibodies  were 
used: rabbit antibodies against V5 (Millipore), pericentrin (Covance), and 
GRASP65 (a gift from N. Nakamura, Kanazawa University, Kanazawa, 
Japan); mouse antibodies against GM130, EB1, and p230 (BD); -tubulin, 
-actin, and acetylated tubulin (Sigma-Aldrich); and goat anti-dyn2 (Santa 
Cruz Biotechnology, Inc.). The following secondary antibodies were used:   
Alexa Fluor 488–conjugated anti–goat IgG and Rhodamine red-X–conjugated 
anti–mouse IgG (Invitrogen); Cy3-conjugated anti–rat IgG (KPL); and HRP-
conjugated anti–mouse IgG, anti–rabbit IgG, and anti–goat IgG (Thermo 
Fisher Scientific). Alexa Fluor 488–conjugated human transferrin was also 
purchased from Invitrogen.
DNA construction
Wild-type and K44A mutant rat dyn2 cDNAs were a gift from M. McNiven 
(Mayo Clinic, Rochester, MN) and were subcloned into pcDNA4 V5/His 
(Invitrogen). Mutations were introduced with QuikChange II XL (Agilent 
Technologies) in accordance with the manufacturer’s instructions, and se-
quences were verified by DNA sequencing. NAGT-GFP was a gift from   
N. Nakamura, and GFP-Rab5 and -Rab11 were gifts from M. Fukuda (Tohoku 
University, Sendai, Japan). DNA was purified for transfection experiments 
by using a Plasmid Maxi kit from QIAGEN.
Cell culture and transfection
COS-7 and HeLa cells were maintained in DME supplemented with 10% 
serum. Transfection was performed by using Effectene (QIAGEN) accord-
ing to the manufacturer’s instructions. The cells were analyzed 48 h after 
transfection. The uptake of transferrin was performed by incubating the 
cells with 25 µg/ml Alexa Fluor 488–conjugated transferrin for 30 min at 
37°C, as described previously (Tanabe et al., 2005). Detergent extraction 
experiments were performed by incubating the cells in Brinkley reassembly 
buffer (BRB80; 80 mM Pipes/KOH, pH 6.8, 4% polyethylene glycol 8000, 
toward the perinuclear region (Fig. 5 C and Video 2). However, 
in dyn2 siRNA cells, we did not observe perinuclear concentra-
tion of the fragmented Golgi, even after 30 min. Furthermore, 
tracking analysis revealed that movement of the fragmented 
Golgi in control siRNA cells repeatedly stopped (Fig. 5 C), 
which might reflect a search and capture behavior (Vaughan, 
2005). However, in the dyn2 siRNA cells, such movement was 
rarely seen. Moreover, although the velocity of the fragmented 
Golgi in dyn2 siRNA cells was comparable with that of control 
cells (Fig. 5 D), the total distance moved was reduced in the 
dyn2 siRNA cells (Fig. 5 E). These results suggest that, although 
movement along microtubules was not altered by dyn2 deple-
tion, microtubule-mediated capture was inhibited. Because pre-
Golgi elements are captured by interacting with EB1, which 
localizes on microtubule plus ends (Vaughan, 2005), the dyn2 
depletion–mediated reduction of EB1 recruitment (Fig. 4 A) 
may be responsible for the fragmentation of the Golgi complex. 
In dyn2 siRNA cells, EB1 was no longer localized in a punctate 
manner at the plus ends of microtubules, whereas the protein 
level was not affected (Fig. 4, A and B), demonstrating that 
dyn2 knockdown caused dislocation of EB1 from microtubule 
plus ends to the cytosol. It is unlikely that dyn2 directly acts on 
EB1 because dyn2 is localized along the entire length of the   
microtubules rather than restricted to the plus ends. However, it 
is plausible that the mislocalization of EB1 in dyn2 siRNA cells 
is a consequence of altered microtubule stability.
To date, dynamin has been found to function in vesicle 
fission in endocytosis (Takei et al., 1995), in actin reorganiza-
tion (Schafer, 2004), and in centrosome cohesion (Thompson   
et al., 2004). This study reveals yet another function, namely in 
dynamic instability of microtubules. We showed that this func-
tion of dyn2 is essential for microtubule-dependent membrane 
transport. It is unlikely that the accumulation of stable micro-
tubules and the fragmentation of the Golgi apparatus are caused 
by dysfunction of the centrosome (Thompson et al., 2004) be-
cause we did not detect impairment of the centrosome in the 
dyn2 siRNA–transfected HeLa cells (Fig. 4 A). Decreased   
microtubule instability might impair capture of pre-Golgi organ-
elles, which is necessary for the formation of the mature Golgi. 
Alternatively, dynamin might be involved in the maintenance of 
cargo attachment to the microtubules. Further examination is 
required to distinguish between these possibilities.
In this study, we demonstrated that different CMT mutants 
affect different membrane transport events. Thus, K558E affects 
endocytosis, whereas 5513 impairs microtubule-dependent 
Table I.  Microtubule dynamic instability parameters
Parameters Control siRNA Dyn2 siRNA
Rate of growth (µm/min) 10.1 ± 6.7 7.9 ± 4.6
Rate of shortening  
  (µm/min)
14.1 ± 9.8 11.6 ± 8.8
Duration of growth (%) 4.2 1.7
Duration of pause (%) 89.7 98.6
Duration of shortening (%) 6.1 0.9
17 and 20 events were measured for control and dyn2 siRNA, respectively, 
and SD is shown.JCB • VOLUME 185 • NUMBER 6 • 2009   946
Figure 5.  Dyn2 is required for the formation of the Golgi complex but not for transport along microtubules. (A) Dyn2 siRNA–treated cells show fragmented 
Golgi but maintain their stacks. HeLa cells were transfected with the indicated siRNAs and visualized with antibodies specific for GRASP65 (green) and 
-tubulin or p230 (red). The boxed areas are enlarged in the insets. (B) Electron micrographs show the Golgi stacks (arrows) in the siRNA-transfected cells. 
(C) HeLa cells expressing NAGT-GFP were transfected with the indicated siRNAs and treated with nocodazole for 2 h. The cells were then washed and 
incubated in the absence of nocodazole. Images were collected every 3 s for 30 min. The signals were tracked manually, and representative tracks are 
shown in different colors. (D and E) The velocity (D) and distance moved (E) by 15 fragments in three cells for each siRNA were measured and averaged. 
The data are represented in arbitrary units (a.u.). The results represent the mean ± SD. Bars: (A and C) 10 µm; (B) 2 µm.947 DYNAMIN REGULATES MICROTUBULE INSTABILITY • Tanabe and Takei
1 mM MgCl2, and 1 mM EGTA) containing 1% Triton X-100 for 10 min at 
37°C (Royle et al., 2005). The cells were washed once with BRB80 without 
Triton X-100, fixed with 3.7% formaldehyde, and processed for immuno-
fluorescence analysis.
RNAi
Human  dyn2–specific  siRNAs  (dyn2  siRNA  1,  5-GGAUAUUGAGGG-
CAAGAAG-3; and dyn2 siRNA 2, 5-GCGAAUCGUCACCACUUAC-3) 
were purchased from Applied Biosystems, as was the negative control 
siRNA. The siRNAs were introduced into HeLa cells by using Lipofectamine 
2000 (Invitrogen) according to the manufacturer’s instructions. The cells 
were analyzed at the indicated times after transfection. For Western blot 
analysis, the cells were lysed in SDS-PAGE sample buffer, boiled for 5 min, 
subjected to SDS-PAGE, and transferred to nitrocellulose membranes. The 
blots were then incubated overnight at 4°C in blocking buffer (140 mM 
NaCl, 1 mM EDTA, and 20 mM Tris-HCl, pH 7.4) containing 5% skim milk 
and 0.02% Tween 20 followed by incubation for 1 h at room temperature 
first with primary antibodies and then with secondary antibodies diluted in 
blocking buffer. The proteins were visualized by using enhanced chemi-
luminescence (GE Healthcare).
Immunofluorescence and electron microscopy
Cells were fixed with 3.7% formaldehyde in PBS for 15 min at room temper-
ature or with 100% methanol for 10 min at 20°C. After three washes with 
PBS, the cells were treated with 1% BSA and 0.1% Triton X-100 in PBS for 
30 min and then incubated with primary antibodies for 45 min at room tem-
perature. After three washes with PBS, the cells were incubated for 30 min 
at room temperature with secondary antibodies. After another three washes 
with PBS, the cells were mounted in PermaFluor (Thermo Fisher Scientific) 
and analyzed by the spinning disc confocal microscope system (CSU10; 
Yokogawa Electric Co.) on an inverted microscope (IX-71; Olympus) equipped 
with an Ar/Kr laser. Images were acquired using a UPlan-Apochromat 100× 
NA 1.35 oil immersion objective (Olympus) and an electron-multiplying 
charge-coupled device camera (iXon; Andor Technology). Image capture 
and acquisition were performed using MetaMorph software (MDS Analyti-
cal Technologies). All images were saved as TIFF files, and brightness and 
contrast were adjusted with ImageJ software (National Institutes of Health). 
For conventional electron microscopy, cells were fixed with 4% paraformal-
dehyde and 2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, for   
10 min at room temperature. The series were observed by using a transmis-
sion electron microscope (H-7100; Hitachi) at the Central Research Labora-
tory at the Okayama University Medical School.
Live imaging and data analysis
HeLa cells stably expressing GFP–-tubulin were a gift from Y. Mimori-Kiyosue 
(Knowledge Action Network Research Institute, Kobe, Japan). To visualize 
the Golgi complex, NAGT-GFP was introduced into HeLa cells by Effec-
tene. The cells were transfected with siRNAs 24 h after DNA transfection 
and then observed 48 h later. To observe Golgi motility, the cells were in-
cubated with 10 µM nocodazole for 2 h and then washed and incubated 
in DME + 10% FBS. The cells were incubated in culture medium and kept 
at 37°C and 5% CO2 using a stage incubator (MI-IBC; Olympus) and digi-
tal gas mixer (GM-2000; Tokai Hit) and imaged using the aforementioned 
confocal system. The quantification and analysis of fluorescent signals was 
performed by using MetaMorph software and ImageJ. Microtubule dynamic 
instability parameters were measured as described previously (Shelden and 
Wadsworth, 1993; Mimori-Kiyosue et al., 2005). In brief, HeLa cells sta-
bly expressing GFP–-tubulin were imaged with a 2-s interval 72 h after 
transfection with siRNAs. Life history plots of 17 microtubules in three con-
trol cells and 20 microtubules in four dyn2 siRNA cells were analyzed. The 
duration of growth/pause/shrinking of microtubules was analyzed as de-
scribed in Shelden and Wadsworth (1993). Rates of growth/shrinking are 
instantaneous (measured within one interval between successive frames). 
All data were analyzed for significance using a Student’s t test.
Online supplemental material
Fig. S1 shows localization of internalized transferrin under the expression 
of the 5513 mutant. Fig. S2 shows the dyn2 siRNA effects on acetylated 
tubulin and EB1 localization. Fig. S3 shows Golgi fragmentation induced 
by the expression of 5513. Videos 1 and 2 show time-lapse experiments 
of HeLa cells stably expressing GFP–-tubulin or NAGT-GFP, respectively, 
that were transfected with control or dyn2 siRNAs.
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